Cresilon is a series c plus startup based in United States. Data sourced from Brouky Intelligence.
About
Cresilon develops advanced hemostatic materials to stop bleeding rapidly. Their technology is based on a proprietary hydrogel that can be applied to wounds of varying severity.
Stage
series-c-plus
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky